Mira Pharmaceuticals Files 8-K

Ticker: MIRA · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1904286

Mira Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyMira Pharmaceuticals, Inc. (MIRA)
Form Type8-K
Filed DateJul 10, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-update, address-change

TL;DR

Mira Pharma updated its address and former name on July 10th.

AI Summary

On July 10, 2025, Mira Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company's principal executive offices are located at 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131. The report also lists a former company name, Mira1a Therapeutics, Inc., with a name change date of January 12, 2022.

Why It Matters

This filing provides updated corporate information and addresses for Mira Pharmaceuticals, Inc., which is important for investors and stakeholders to maintain accurate records.

Risk Assessment

Risk Level: low — The filing is a routine update of corporate information and does not disclose any new material events, financial changes, or strategic shifts.

Key Players & Entities

  • Mira Pharmaceuticals, Inc. (company) — Registrant
  • July 10, 2025 (date) — Date of Report
  • 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131 (address) — Principal Executive Offices
  • Mira1a Therapeutics, Inc. (company) — Former Company Name
  • January 12, 2022 (date) — Date of Name Change

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report current information as of July 10, 2025, including the company's principal executive offices and its former name.

When was the company's name last changed?

The company's name was last changed on January 12, 2022, from Mira1a Therapeutics, Inc. to Mira Pharmaceuticals, Inc.

What is the new principal executive office address?

The new principal executive office address is 1200 Brickell Avenue, Suite 1950 #1183, Miami, Florida 33131.

What is the exact name of the registrant?

The exact name of the registrant is Mira Pharmaceuticals, Inc.

What is the company's state of incorporation?

The company's state of incorporation is Florida.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding MIRA PHARMACEUTICALS, INC. (MIRA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.